These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 30924270)

  • 1. Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study.
    da Rocha IMG; Marcadenti A; de Medeiros GOC; Bezerra RA; Rego JFM; Gonzalez MC; Fayh APT
    J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):445-454. PubMed ID: 30924270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients.
    Anandavadivelan P; Brismar TB; Nilsson M; Johar AM; Martin L
    Clin Nutr; 2016 Jun; 35(3):724-30. PubMed ID: 26065721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-Related Toxicity, Nutritional Status and Quality of Life in Precachectic Oncologic Patients with, or without, High Protein Nutritional Support. A Prospective, Randomized Study.
    Ziętarska M; Krawczyk-Lipiec J; Kraj L; Zaucha R; Małgorzewicz S
    Nutrients; 2017 Oct; 9(10):. PubMed ID: 29019951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.
    Martin L; Birdsell L; Macdonald N; Reiman T; Clandinin MT; McCargar LJ; Murphy R; Ghosh S; Sawyer MB; Baracos VE
    J Clin Oncol; 2013 Apr; 31(12):1539-47. PubMed ID: 23530101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
    Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
    Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients.
    Kurk S; Peeters P; Stellato R; Dorresteijn B; de Jong P; Jourdan M; Creemers GJ; Erdkamp F; de Jongh F; Kint P; Simkens L; Tanis B; Tjin-A-Ton M; Van Der Velden A; Punt C; Koopman M; May A
    J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):803-813. PubMed ID: 31094083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The abridged patient-generated subjective global assessment is a useful tool for early detection and characterization of cancer cachexia.
    Vigano AL; di Tomasso J; Kilgour RD; Trutschnigg B; Lucar E; Morais JA; Borod M
    J Acad Nutr Diet; 2014 Jul; 114(7):1088-1098. PubMed ID: 24462323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.
    Dijksterhuis WPM; Pruijt MJ; van der Woude SO; Klaassen R; Kurk SA; van Oijen MGH; van Laarhoven HWM
    J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):199-206. PubMed ID: 30666831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional status and functional status of the pancreatic cancer patients and the impact of adjacent symptoms.
    Santos I; Mendes L; Mansinho H; Santos CA
    Clin Nutr; 2021 Nov; 40(11):5486-5493. PubMed ID: 34656030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact.
    Prado CM; Cushen SJ; Orsso CE; Ryan AM
    Proc Nutr Soc; 2016 May; 75(2):188-98. PubMed ID: 26743210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are measures and related symptoms of cachexia recorded as outcomes in gastrointestinal cancer chemotherapy clinical trials?
    Valaire R; Garden F; Razmovski-Naumovski V
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1146-1156. PubMed ID: 38533530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study.
    Järvinen T; Ilonen I; Kauppi J; Salo J; Räsänen J
    World J Surg Oncol; 2018 Feb; 16(1):27. PubMed ID: 29433514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel intervention with acupuncture for anorexia and cachexia in patients with gastrointestinal tract cancers: a feasibility study.
    Yoon SL; Grundmann O; Williams JJ; Carriere G
    Oncol Nurs Forum; 2015 Mar; 42(2):E102-9. PubMed ID: 25806891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer.
    Tan BH; Brammer K; Randhawa N; Welch NT; Parsons SL; James EJ; Catton JA
    Eur J Surg Oncol; 2015 Mar; 41(3):333-8. PubMed ID: 25498359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy.
    Shachar SS; Deal AM; Weinberg M; Nyrop KA; Williams GR; Nishijima TF; Benbow JM; Muss HB
    Clin Cancer Res; 2017 Feb; 23(3):658-665. PubMed ID: 27489287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of sarcopenia on nutritional status in elderly patients with gastrointestinal tumors.
    Ai D; Ding N; Wu H
    Sci Rep; 2023 Jun; 13(1):10308. PubMed ID: 37365298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenia assessment by new EWGSOP2 criteria for predicting chemotherapy dose-limiting toxicity in patients with gastrointestinal tract tumors.
    Celik E; Suzan V; Samanci NS; Suzan AA; Karadag M; Sahin S; Aslan MS; Yavuzer H; Demirci NS; Doventas A; Demirelli FH
    Eur Geriatr Med; 2022 Feb; 13(1):267-274. PubMed ID: 34826111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients.
    de Jong C; Chargi N; Herder GJM; van Haarlem SWA; van der Meer F; van Lindert ASR; Ten Heuvel A; Brouwer J; de Jong PA; Devriese LA; Huitema ADR; Egberts TCG; de Bree R; Deneer VHM
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1554-1564. PubMed ID: 35301821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hand grip strength in patients with advanced cancer: A prospective study.
    Hadzibegovic S; Porthun J; Lena A; Weinländer P; Lück LC; Potthoff SK; Rösnick L; Fröhlich AK; Ramer LV; Sonntag F; Wilkenshoff U; Ahn J; Keller U; Bullinger L; Mahabadi AA; Totzeck M; Rassaf T; von Haehling S; Coats AJS; Anker SD; Roeland EJ; Landmesser U; Anker MS
    J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1682-1694. PubMed ID: 37318103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A window beneath the skin: how computed tomography assessment of body composition can assist in the identification of hidden wasting conditions in oncology that profoundly impact outcomes.
    Daly LE; Prado CM; Ryan AM
    Proc Nutr Soc; 2018 May; 77(2):135-151. PubMed ID: 29745361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.